Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E S Lapotentova"'
Autor:
Yu V Rumyantseva, A I Karachunsky, O V Aleinikova, L G Fechina, A V Shamardina, D V Litvinov, N I Ponomareva, E G Boichenko, S A Dudkin, O V Streneva, K L Kondratchik, E G Mansurova, L M Minkina, E S Lapotentova, E V Inyushkina, N B Yudina, G P Pavlova, E V Zhukovskaya, O P Khlebnikova, S N Lagoiko, E V Basharova, R E Denisov, V D Zlobina, E S Banshchikova, K S Aslanyan, E V Kondakova, E V Tselousova, N V Myakova, T V Turobova, O V Ryskal, N F Chipsanova, S R Varfolomeyeva, A G Rumyantsev
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 11-19 (2010)
Aim. To evaluate the efficiency of the original ALL-MB-2002 protocol within the multicenter study of treatment of acute lymphoblastic leukemia (ALL) in children. Subjects and methods. A total of 1873 primary patients with ALL aged 1 to 18 years, of w
Externí odkaz:
https://doaj.org/article/cfbc2ada713446ef93c73a86b57fd3bc
Autor:
M. Yu. Goroshkova, Yu. V. Rumyantseva, O. V. Aleinikova, S. A. Dudkin, L. G. Fechina, A. V. Shamardina, O. V. Streneva, K. L. Kondratchik, L. M. Minkina, E. S. Lapotentova, E. V. Inyushkina, O. B. Kozlova, E. V. Zhukovskaya, O. P. Khlebnikova, E. V. Basharova, V. N. Timofeeva, G. P. Pavlova, V. D. Zlobina, O. A. Utrobina, E. S. Banshchikova, K. S. Aslanyan, E. V. Kondakova, E. V. Tselousova, N. V. Myakova, T. V. Turobova, O. V. Ryskal, O. Yu. Fuks, V. V. Lebedev, N. F. Chipsanova, S. R. Varfolomeeva, A. I. Karachunsky
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 25-33 (2022)
The paper presents the results of a multicenter randomized study of two-dose COLI-ASP regimens in therapy of consolidation of standard risk-group (SRG) children and adolescents with acute lymphoblastic leukemia (ALL) treated by the ALL-MB-2002 protoc
Externí odkaz:
https://doaj.org/article/273ffc5c215a492e9db3020d5e11e678
Autor:
J. V. Roumiantseva, A. I. Karachunsky, O. V. Aleinikova, L. G. Fechina, A. V. Schamardina, D. V. Litvinov, N. I. Ponomareva, E. G. Boichenko, L. V. Sidorenko, S. A. Dudkin, O. V. Streneva, K. L. Kondratchik, E. G. Mansurova, L. M. Minkina, E. S. Lapotentova, E. V. Inuschkina, N. B. Yudina, G. P. Pavlova, E. V. Zhukovskaya, O. P. Chlebnikova, S. N. Lagoiko, E. V. Bascharova, R. E. Denisov, V. D. Zlobina, E. S. Banschikova, K. S. Aslanyan, E. V. Kondakova, E. V. Celousova, N. V. Myakova, T. V. Turobova, O. V. Riskal, N. F. Chipsanova, S. R. Varfolomeeva, A. G. Rumiantsev
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 37-49 (2022)
Проанализирована значимость прогностических факторов эффективности терапии у детей с острым лимфобластным лейкозом (ОЛЛ), получающих
Externí odkaz:
https://doaj.org/article/60da326014b14be09d19043fc252c8e4
Autor:
G. A. Tsaur, A. M. Popov, O. V. Aleynikova, E. G. Boychenko, T. Yu. Verzhbitskaya, E. V. Volochnik, A. S. Ivanova, O. V. Kalennik, S. Yu. Kovalev, K. L. Kondtratchik, A. M. Kustanovich, E. S. Lapotentova, D. V. Litvinov, I. S. Martynkevich, N. V. Myakova, T. V. Nasedkina, V. A. Ovsepyan, Yu. V. Olshanskaya, O. M. Plehanova, A. V. Popa, T. O. Riger, L. I. Savelyev, O. V. Streneva, M. V. Strigaleva, I. V. Shmunk, E. V. Shorikov, L. G. Fechina
Publikováno v:
Онкогематология, Vol 6, Iss 3, Pp 57-64 (2014)
117 cases of infant acute lymphoblastic leukemia without Down syndrome (aged from 1 to 365 days) were included in the current study.Rearrangements of 11q23 (MLL) were revealed in 74 (63.2 %) patients. Among this group the most common rearrangement wa
Externí odkaz:
https://doaj.org/article/4bfa81f4024c4578befd7cdbdb10d236
Autor:
G. A. Tsaur, A. M. Popov, O. V. Aleynikova, E. G. Boychenko, T. Yu. Verzhbitskaya, E. V. Volochnik, A. S. Ivanova, O. V. Kalennik, S. Yu. Kovalev, K. L. Kondtratchik, A. M. Kustanovich, E. S. Lapotentova, D. V. Litvinov, I. S. Martynkevich, N. V. Myakova, T. V. Nasedkina, V. A. Ovsepyan, Yu. V. Olshanskaya, O. M. Plehanova, A. V. Popa, T. O. Riger, L. I. Savelyev, O. V. Streneva, M. V. Strigaleva, I. V. Shmunk, E. V. Shorikov, L. G. Fechina
Publikováno v:
Onkogematologiâ, Vol 6, Iss 3, Pp 57-64 (2014)
117 cases of infant acute lymphoblastic leukemia without Down syndrome (aged from 1 to 365 days) were included in the current study. Rearrangements of 11q23 (MLL) were revealed in 74 (63.2 %) patients. Among this group the most common rearrangement w